Cough, Cold and Allergy (Hay Fever) Remedies in Poland

Summary

Euromonitor International's Cough, Cold and Allergy Products in Poland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

• Get a detailed picture of the cough, cold and allergy (hayfever) industry
• Identify factors driving change
• Understand the competitive environment, the market's major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

• Cough, Cold and Allergy (hay Fever) Remedies in Poland
• Euromonitor International
• April 2009
• Executive Summary
• Increased Spending on OTC Drugs
• New Innovative Products Fuel Demand
• Multinationals Dominate Sales
• Non-pharmacy Channel Sales Continue To Increase
• Further Growth Expected
• Key Trends and Developments
• Health and Wellness Trend Increases in Popularity
• Self-medication Increases in Popularity
• Lifestyle and Environmental Changes Shape Consumer Behaviour
• Innovations Fuel Growth
• Increasing Child-specific Product Sales
• Market Indicators
• Market Data
• $1OTC Registration and Classification
• Vitamins & Dietary Supplements Registration and Classification
• EU Legislation
• Self-medication and Preventative Medicine
• Generics
• Re-classifications
• Definitions
• Aflofarm Farmacja Polska Sp Zoo
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Jelfa SA
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Polpharma SA
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Polski Lek SA
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Ppf Hasco-lek SA
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Headlines
• Trends
• Re-classifications
• Competitive Landscape
• Prospects
• Sector Data
• List of Summaries
  • Summary 1 OTC healthcare Switches 2005-2007
  • Summary 2 Research Sources
  • Summary 3 Aflofarm Farmacja Polska Sp zoo: Key Facts
  • Summary 4 Aflofarm Farmacja Polska Sp zoo: Operational Indicators
  • Summary 5 Aflofarm Farmacja Polska Sp zoo: Production Statistics 2007
  • Summary 6 Aflofarm Farmacja Polska Sp zoo: Competitive Position 2008
  • Summary 7 Jelfa SA: Key Facts
  • Summary 8 Jelfa SA: Operational Indicators
  • Summary 9 Jelfa SA: Production Statistics 2007
  • Summary 10 Jelfa SA: Competitive Position 2008
  • Summary 11 Polpharma SA: Key Facts
  • Summary 12 Polpharma SA: Operational Indicators
  • Summary 13 Polpharma SA: Production Statistics 2007
  • Summary 14 Polpharma SA: Competitive Position 2008
  • Summary 15 Polski Lek SA: Key Facts
  • Summary 16 Polski Lek SA: Operational Indicators
  • Summary 17 Polski Lek SA: Production Statistics 2007
  • Summary 18 Polski Lek SA: Competitive Position 2008
  • Summary 19 PPF Hasco-Lek SA: Key Facts
  • Summary 20 PPF Hasco-Lek SA: Operational Indicators
  • Summary 21 PPF Hasco-Lek SA: Production Statistics 2007
  • Summary 22 PPF Hasco-Lek SA: Competitive Position 2008
• List of Tables
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
  • Table 2 Life Expectancy at Birth 2003-2008
  • Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
  • Table 5 OTC Healthcare Company Shares by Value 2004-2008
  • Table 6 OTC Healthcare Brand Shares by Value 2005-2008
  • Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
  • Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
  • Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
  • Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
  • Table 11 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
  • Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
  • Table 13 Sales of Decongestants by Type: Value 2003-2008
  • Table 14 Sales of Decongestants by Type: % Value Growth 2003-2008
  • Table 15 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
  • Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
  • Table 17 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
  • Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
  • Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
  • Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
  • Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013